You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator

 

Online download statistics by month:

Online download statistics by month: September 2022 to September 2024

AbstractFullPdf
Sep 2022356379177
Oct 2022470483128
Nov 202215315458
Dec 202210610832
Jan 202311511532
Feb 202310810940
Mar 20239910125
Apr 2023545419
May 2023353722
Jun 2023353515
Jul 2023434322
Aug 2023222212
Sep 2023323211
Oct 2023525222
Nov 2023343614
Dec 2023565632
Jan 2024404123
Feb 2024434318
Mar 2024576075
Apr 2024373733
May 2024596039
Jun 2024414015
Jul 2024474926
Aug 2024414015
Sep 2024515327
Total21862239932